CRT 2025

Power Break Symposium

Panel Discussion

Panel Moderator(s)

• 

  Wayne Batchelor, MD, MHS

  Director, Interventional Cardiology and Interventional Research and Innovation
  Inova Heart & Vascular Institute
  Falls Church, Virginia, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Chiesi USA: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Jeffrey W. Moses, MD, FSCAI

  John and Myrna Daniels Professor of Cardiology
  Columbia University Medical Center
  New York, New York, United States

  Disclosure(s): Covanos Inc.: Stock-privately held company (Ongoing); Orchestra Biomed: Stock-privately held company (Ongoing); OSTIAL Corp: Stock-privately held company (Ongoing); Weightless Lead: Stock-privately held company (Ongoing); Xenter Inc: Stock-privately held company (Ongoing)

Panel Discussant(s)

• 

  Suhail Dohad, MD

  Medical director of aortic and ischemic limb disease. Director of complex PCI/Endovascular fellowship
  Cedars Sinai Medical Center
  Beverly Hills, California, United States

  Disclosure(s): Abbott Vascular, Boston Scientific, Penumbra, Phillips, ReCOR/Otsuka Pharmaceuticals, Johnson and Johnson: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Angela M. Taylor, MD, MS, MBA

  Professor
  University of Virginia
  Charlottesville, Virginia, United States

  Disclosure(s): No financial relationships to disclose